Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA 'Evolving' Homeopathic Drug Enforcement With Risk-Based Approach

Dec 20 2017

• By Malcolm Spicer

Related Content

Zicam Lawsuits Multiply, But Matrixx Is Confident History Will Repeat Itself

Jun 29 2009

Inspection, AERs Prompt <i>Hyland's Teething Tablets</i> Recall

Nov 08 2010

FDA Examination Of Homeopathic Regulation Looks Beyond Safety History

Apr 27 2015

FTC Homeopathic Disclaimer Policy Should Prompt FDA Changes – Advocacy Group

Nov 21 2016

OTC Homeopathic Labels Must Include Scientific Disclaimers – FTC

Nov 16 2016

Additional Topics

Regulation Ingredients FDA Safety Cosmetics Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window